CD28 and myeloid sarcoma: Of note, the Treg subsets, which showed to be decreased in patients with MS as compared to healthy individuals, expressed CD28 and some Treg subsets expressed invariably CD27 (Figures 2 and 3) consistent with the notion that CD28 engagement controls homeostasis of CD4+CD25+ Treg cells [10].